Literatur
-
1
Cady R, Schreiber C.
Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Headache.
2008;
48
900-913
-
2 Diener H C, Putzki N. Therapie der Migräne. Leitlinien für Diagnostik und Therapie in der Neurologie. Kommission „Leitlinien” der Deutschen Gesellschaft für Neurologie Stuttgart; Thieme 2008 4. Aufl
-
3
Dirnberger F, Becker K.
Surgical treatment of migraine headaches by corrugator muscle resection.
Plast Reconstr Surg.
2004;
114
652-657
-
4
Guyuron B, Kriegler J S, Davis J. et al .
Comprehensive surgical treatment of migraine headaches.
Plast Reconstr Surg.
2005;
115
1-9
-
5
Guyuron B, Varghai A, Michelow B J. et al .
Corrugator supercilii muscle resection and migraine headaches.
Plast Reconstr Surg.
2000;
106
429-434
-
6
Guyuron B, Michelow B J, Thomas T.
Corrugator supercilii muscle resection through blepharoplasty incision.
Plast Reconstr Surg.
1995;
95
691-696
-
7
Hornblass A, Herschorn B J, Mines J.
Preseptal cellulitis in frontalis suspension for congenital ptosis.
Plast Reconstr Surg.
1984;
74
574-575
-
8
Liu I T, Kao S C, Wang A G. et al .
Preseptal and orbital cellulitis: a 10-year review of hospitalized patients.
J Chin Med Assoc.
2006;
69
415-422
-
9
Muehlberger T, Fischer P, Lehnhardt M.
Die Anatomie der chirurgischen Migränetherapie.
Zentralbl Chir.
2005;
130
288-292
PD Dr. Antonio Bergua
Augenklinik mit Poliklinik, Universität Erlangen-Nürnberg
Schwabachanlage 6
91054 Erlangen
Phone: ++ 49/91 31/8 54 43 46
Fax: ++ 49/91 31/85 44 36
Email: antonio.bergua@uk-erlangen.de
